In this blog for people with severe arthritis Robert Walton, Senior Fellow in General Practice at Cochrane UK and a very general practitioner, examines Cochrane evidence about biologics, a new generation of drugs to help people with this disabling long term condition.
Rivastigmine reviewed: doubts about dementia drug
In this blog for our dementia series, nurse Helen Cowan reflects on Cochrane evidence on rivastigmine and the use of this drug in practice.
Should the Cochrane logo be accompanied by a health warning?
In the second blog of our new series Understanding Evidence, Iain Chalmers, our founding director, looks at developments in research on prenatal...
Superbugs: real problem, real work
‘Superbugs’ have hit the headlines again. As the 193 countries of the United Nations pass round the pen and...